Showing results (121-130 of 136) with videos related to
Sort By:
Pageof 14
Journal of Thrombosis and Haemostasis : JTH|August 24, 2017
A novel protein C-factor VII chimera provides new insights into the structural requirements for cytoprotective protease-activated receptor 1 signalingE M Gleeson, C J McDonnell, E E Soule, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1993
Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experienceP H McWhinney, C C Kibbler, M D Hamon, et al.The British Journal of Dermatology|June 19, 2007
Fabry disease and the skin: data from FOS, the Fabry outcome surveyC H Orteu, T Jansen, O Lidove, et al.British Journal of Haematology|February 1, 1991
Interleukin 2 infusion induces haemopoietic growth factors and modifies marrow regeneration after chemotherapy or autologous marrow transplantationH E Heslop, A S Duncombe, J E Reittie, et al.Irish Journal of Medical Science|May 8, 2002
Thermolabile methylenetetrahydrofolate reductase (C677T): frequency in the Irish populationL A Mynett-Johnson, C Keenan, I L Black, et al.Oncogene|May 6, 1998
Herbimycin A accelerates the induction of apoptosis following etoposide treatment or gamma-irradiation of bcr/abl-positive leukaemia cellsF A Riordan, C A Bravery, K Mengubas, et al.British Journal of Haematology|September 1, 1993
Recombinant interferon alfa 2a in the treatment of patients with early stage B chronic lymphocytic leukaemiaE N McSweeney, F J Giles, C P Worman, et al.British Journal of Haematology|September 13, 2001
Autologous plasma activates Akt/protein kinase B and enhances basal survival and resistance to DNA damage-induced apoptosis in B-chronic lymphocytic leukaemia cellsR G Wickremasinghe, K Ganeshaguru, D T Jones, et al.Bone Marrow Transplantation|July 1, 1991
Failure of purged autologous bone marrow transplantation in high risk acute lymphoblastic leukaemia in first complete remissionM J Gilmore, M D Hamon, H G Prentice, et al.Lancet (London, England)|July 9, 1988
Alpha-interferon therapy for essential thrombocythaemiaF J Giles, C R Singer, A G Gray, et al.Pageof 14